Skip to main content

Clinical Trial Registries, Results Databases, and Research Data Repositories

  • Chapter
  • First Online:
Clinical Research Informatics

Abstract

Trial registration, results disclosure, and sharing of analyzable individual participant data (IPD) are considered powerful tools for achieving higher levels of transparency and accountability for clinical trials. The emphasis on disseminating knowledge and growing demands for transparency in clinical research are contributing to a major paradigm shift in health research. In this new paradigm, knowledge will be generated from the culmination of all existing knowledge—not just from bits and parts of previous knowledge, as has been largely the case until now. Fully transparent clinical research diminishes publication bias, increases accountability, avoids unnecessary duplication of research (and thus avoid research waste), efficiently advances research, provides more reliable evidence for diagnostic and therapeutic interventions, regains public trust, and contributes to research integrity. Transparency of clinical trials, at a minimum, means sharing information about the trial design, conduct, and results, as well as the analyzable data. Not only must the information itself be explicitly documented, but an access location or medium for distribution also must be provided. Thus, transparency is realized by making research protocols, results, and cleaned and anonymized IPDs publicly available using well-defined, freely accessible electronic tools. Many electronic tools enabling sharing clinical trial information have emerged. These tools include registries hosting protocol data, results databases hosting aggregate data, and research data repositories hosting reusable and analyzable data sets and other research-related information. These tools are at different levels of development and are plagued with heterogeneity as international standards for trial registration do not yet address the sharing of individual patient data. Additionally, the need to measure and improve clinical trial transparency has led to development of specific electronic tools. This chapter is relevant for any professional involved in clinical trials and the use of the knowledge generated from them, including clinical and biomedical researchers, clinical trialists, systematic reviewers, information technology and informatics specialists, patients, journal editors, and public and private research funders and sponsors. Suggested competencies and learning activities for specific roles are presented at the end of the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO. International Clinical Trials Registry Platform (ICTRP) [Internet]. [cited 2022 Mar 28]. https://www.who.int/clinical-trials-registry-platform.

  2. WCRIF. Mission—World Conferences on Research Integrity [Internet]. [cited 2022 May 10]. https://wcrif.org/foundation/mission.

  3. Vickers AJ. Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?” Trials [Internet]. 2016;17:227. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855346/.

  4. Krleža-Jerić K. Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med. 2005;2:1093–7.

    Article  Google Scholar 

  5. Clinical Study Data Request [Internet]. [cited 2016 Aug 31]. https://www.clinicalstudydatarequest.com/.

  6. Project Data Sphere [Internet]. [cited 2016 Jul 31]. https://www.projectdatasphere.org/.

  7. YODA Project [Internet]. [cited 2016 Jul 18]. http://yoda.yale.edu/.

  8. Vivli—A global Clinical trial data sharing platform: proposal, definition and scope background and objectives. 2016;(June). https://vivli.org.

  9. European Medicines Agency—Clinical data publication—Documents from advisory groups on clinical-trial data [Internet]. [cited 2018 Aug 20]. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/document_listing/document_listing_000368.jsp&mid=WC0b01ac05809f3f12#section1.

  10. Krleža-Jerić K. Sharing of data from clinical trials and research integrity. In: Steneck N, Anderson M, Kleinert S, Mayer T, editor. Integrity in the Global Research Arena; Proceedings of the World Conference on Research Integrity; 3rd, Montreal 2013. World Scientific Publisher, Singapore. p 91.

    Google Scholar 

  11. Krleža-Jerić K. Sharing of clinical trial data and research integrity. Period Biol. 2014;116(4):337–9.

    Google Scholar 

  12. Krleža-Jerić K. Clinical trials registries and results databases. In: Richesson RL, Andrews JE, editors. Clinical research informatics. London: Springer; 2012. p. 389–408.

    Chapter  Google Scholar 

  13. Chan AW, Hróbjartsson A. Promoting public access to clinical trial protocols: challenges and recommendations. Trials. 2018;19(1):116.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Clinical Trial Transparency | Transparimed [Internet]. 2019 [cited 2022 Mar 30]. https://www.transparimed.org/.

  15. Krleza-Jeric K. Clinical trial registries, results databases, and research data repositories. In: Richesson RL, Andrews JE, editors. Clinical research informatics. 2nd ed. Springer International; 2019. p. 453–480.

    Google Scholar 

  16. Krleza-Jerić K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ [Internet]. 2005 [cited 2016 Jul 13];330(7497):956–8. http://www.ncbi.nlm.nih.gov/pubmed/15845980.

  17. Krleza-Jeric K. IMPACT Observatory [Internet]. MedILS. [cited 2022 Jun 4]. https://www.medils.org/research/impact-observatory.

  18. RDA. About RDA | RDA [Internet]. 2016 [cited 2022 Jun 3]. https://www.rd-alliance.org/about-rda.

  19. Good Pharma Scorecard | Bioethics International [Internet]. 2009 [cited 2022 Mar 30]. https://bioethicsinternational.org/good-pharma-scorecard/.

  20. Miller J, Ross JS, Wilenzick M, Mello MM. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices. BMJ. 2019;366:l4217.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Goldacre B, Devito NJ, Heneghan C, Irving F, Bacon S, Fleminger J, et al. Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource. BMJ [Internet]. 2018 [cited 2021 Nov 26];362:3218. https://doi.org/10.1136/bmj.k3218.

  22. WHO Global Observatory Clin trials. Number of clinical trials by year, country, region and income group [Internet]. 2022 [cited 2022 May 10]. https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/number-of-clinical-trials-by-year-country-who-region-and-income-group.

  23. WHO News. Joint statement on public disclosure of results from clinical trials [Internet]. 2017 [cited 2022 May 27]. https://www.who.int/news/item/18-05-2017-joint-statement-on-registration.

  24. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol [Internet]. 1986 [cited 2016 Jul 13];4(10):1529–41. http://www.ncbi.nlm.nih.gov/pubmed/3760920.

  25. Bass A. Side effects; A prosecutor, whistelblower, and a bestselling antidepressant on trial. 1st ed. Algonquin Books of Chapel Hill; 2008. 260 p.

    Google Scholar 

  26. Gibson L. GlaxoSmithKline to publish clinical trials after US lawsuit. BMJ. 2004;328(7455):1513.

    Article  PubMed  PubMed Central  Google Scholar 

  27. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the international committee of medical journal editors. JAMA [Internet]. 2004 [cited 2016 Jul 12];292(11):1363–4. http://www.ncbi.nlm.nih.gov/pubmed/15355936.

  28. World Health Organisation. Ministerial Summit on Health Research Report by the Secretariat. 2005.

    Google Scholar 

  29. International Clinical Trials Registry Platform (ICRTP) [Internet]. [cited 2016 Jul 11]. https://www.who.int/clinical-trials-registry-platform.

  30. Mahmić-Kaknjo M, Šimić J, Krleža-Jerić K. Setting the impact (Improve access to clinical trial data) observatory baseline. Biochem Med [Internet]. 2018;28(1):010201. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806612/.

  31. ISRCTN. ISRCTN Registry [Internet]. [cited 2022 Jun 2]. https://www.isrctn.com/.

  32. NIH-NLM. ClinicalTrials.gov [Internet]. [cited 2022 May 27]. https://clinicaltrials.gov/.

  33. Cho SM, Serghiou S, Ioannidis JPA, Klassen TP, Contopoulos-Ioannidis DG. Large pediatric randomized clinical trials in ClinicalTrials.gov download large pediatric randomized clinical trials in ClinicalTrials.gov. Pediatrics. 2021;148(3):e2020049771.

    Article  PubMed  Google Scholar 

  34. Chan AW, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet [Internet]. 2013 [cited 2022 Mar 26];381(9861):91–2. http://www.thelancet.com/article/S0140673612621606/fulltext.

  35. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J a, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ [Internet]. 2013;346:e7586. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3541470&tool=pmcentrez&rendertype=abstract.

  36. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Emam K el, Jonker E, Sampson M, Krleža-Jerić K, Neisa A. The use of electronic data capture tools in clinical trials: web-survey of 259 Canadian trials. J Med Internet Res [Internet]. 2009 [cited 2022 Mar 26];11(1). /pmc/articles/PMC2762772/.

    Google Scholar 

  38. Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols the SPIRIT-PRO extension. JAMA [Internet]. 2018;319(5):483–94. https://jamanetwork.com/.

  39. Dai L, Cheng CW, Tian R, Zhong LL, Li YP, Lyu AP, et al. Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: recommendations, explanation and elaboration (SPIRIT-TCM Extension 2018). Chin J Integr Med [Internet]. 2019 [cited 2022 Mar 27];25(1):71–9. https://pubmed.ncbi.nlm.nih.gov/30484022/.

  40. Cruz Rivera S, Liu X, Chan AW, Denniston AK, Calvert MJ, Ashrafian H, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Lancet Digital Health. 2020;2(10):e549–60.

    Article  PubMed  Google Scholar 

  41. Porcino AJ, Shamseer L, Chan AW, Kravitz RL, Orkin A, Punja S, et al. SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist. BMJ [Internet]. 2020 [cited 2022 Mar 27]; https://doi.org/10.1136/bmj.m122. http://www.bmj.com/.

  42. EQUATOR. The EQUATOR Network | Enhancing the QUAlity and Transparency Of Health Research [Internet]. [cited 2022 May 26]. https://www.equator-network.org/.

  43. https://www.icmje.org/about-icmje/faqs/clinical-trials-registration/

  44. WHO trial registration data set version 1.3.1. [Internet]. [cited 2022 Mar 24]. https://www.who.int/clinical-trials-registry-platform/network/who-data-set.

  45. Bhatia P, Mohammed S. Observational study design: extending the standard. J Anaesthesiol Clin Pharmacol [Internet]. 2021 [cited 2022 Jan 7];37(3):317–8. https://pubmed.ncbi.nlm.nih.gov/34759537/.

  46. Bradley SH, Lloyd KE, Devito NJ. Automatic registration for UK trials. A welcome development, not a panacea. BMJ [Internet]. 2022 [cited 2022 Jan 29]; https://doi.org/10.1136/bmj.o41.

  47. UMIN-ICDR Individual Case data repository [Internet]. [cited 2018 Aug 11]. http://www.umin.ac.jp/icdr/index.html.

  48. Banzi R, Canham S, Kuchinke W, Krleza-Jeric K, Demotes-Mainard J, Ohmann C. Evaluation of repositories for sharing individual-participant data from clinical studies. Trials [Internet]. 2019 [cited 2022 Feb 12];20(1). https://pubmed.ncbi.nlm.nih.gov/30876434/.

  49. Reveiz L, Chan AW, Krleza-Jerić K, Granados CE, Pinart M, Etxeandia I, et al. Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal. PLoS One [Internet]. 2010;5(8):e12484. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012484.

  50. Reveiz L, Krleza-Jerić K, Chan AW, de Aguiar S. Do trialists endorse clinical trial registration? Survey of a PubMed sample. Trials [Internet]. 2007;8:30. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2147029&tool=pmcentrez&rendertype=abstract.

  51. Harriman SL, Patel J. When are clinical trials registered? An analysis of prospective versus retrospective registration. Trials [Internet]. 2016;17:187. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832501/.

  52. Gray R, Brown E, Gray G. A review of prospective trial registration in the Journal of Advanced Nursing in 2018. J Adv Nurs [Internet]. 2019 Oct 1 [cited 2021 Nov 15];75(10):2051–3. https://onlinelibrary.wiley.com/doi/full/10.1111/jan.14090.

  53. Venugopal N, Saberwal G. A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one. Plos One [Internet]. 2021. https://doi.org/10.1371/journal.pone.0251191.

  54. Taylor NJ, Gorman DM. Registration and primary outcome reporting in behavioral health trials. BMC Med Res Methodol. 2022;22(1):41.

    Article  PubMed  PubMed Central  Google Scholar 

  55. WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects—WMA—The World Medical Association [Internet]. 2013 [cited 2018 Aug 19]. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.

  56. Krleza-Jerić K, Lemmens T. 7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials. Croat Med J [Internet]. 2009 [cited 2016 Jul 13];50(2):105–10. http://www.ncbi.nlm.nih.gov/pubmed/19399942.

  57. Goodyear MDE, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. BMJ [Internet]. 2007 [cited 2016 Jul 13];335(7621):624–5. http://www.ncbi.nlm.nih.gov/pubmed/17901471.

  58. Zarin DA, Tse T, Williams RJ, Rajakannan T. The status of trial registration eleven years after the ICMJE policy. N Engl J Med [Internet]. 2017;376(4):383–91. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813248/.

  59. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. Ioannidis J, editor. PLoS Med [Internet]. 2008;5(11):e217. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586350/.

  60. CDISC [Internet]. [cited 2018 Aug 19]. https://www.cdisc.org/.

  61. Morley RL, Edmondson MJ, Rowlands C, Blazeby JM, Hinchliffe RJ. Registration and publication of emergency and elective randomised controlled trials in surgery: a cohort study from trial registries. BMJ Open [Internet]. 2018 Jul 1 [cited 2022 Mar 29];8(7). https://pubmed.ncbi.nlm.nih.gov/29982216/.

  62. Greiner B, Corcoran A, Wheeler D. Clinical trial registry searches are under-utilized in systematic reviews from critical care journals: a bibliometric analysis. J Crit Care. 2021;63:175–8.

    Article  PubMed  Google Scholar 

  63. Riedl D, Rothmund M, Darlington AS, Sodergren S, Crazzolara R, de Rojas T. Rare use of patient-reported outcomes—in childhood cancer clinical trials—a systematic review of clinical trial registries. Eur J Cancer [Internet]. 2021 [cited 2021 Nov 14];152:90–9. http://creativecommons.org/licenses/by-nc-nd/4.0/.

  64. Yerokhin VV, Carr BK, Sneed G, Vassar M. Clinical trials registries are underused in the pregnancy and childbirth literature: a systematic review of the top 20 journals. BMC Res Notes. 2016;9(1):475.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Dear RF, Barratt AL, McGeechan K, Askie L, Simes J, Tattersall MHN. Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Med J Aust [Internet]. 2011 [cited 2022 Mar 29];194(8):387–91. https://pubmed.ncbi.nlm.nih.gov/21495937/.

  66. Ecker BL, Brajcich BC, Ellis RJ, Ko CY, D’Angelica MI. Registry-based randomized clinical trials in surgery: working with ACS-NSQIP and the AHPBA to conduct pragmatic trials. J Surg Oncol [Internet]. 2022 [cited 2022 Jan 4];125(1):89–92. https://onlinelibrary.wiley.com/doi/10.1002/jso.26742.

  67. Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021. https://doi.org/10.1136/bmj.n71.

  68. Reddy AK, Anderson JM, Gray HM, Fishbeck K, Vassar M. Clinical trial registry use in orthopaedic surgery systematic reviews. J Bone Joint Surg Am [Internet]. 2021 [cited 2022 Mar 28];103(10):e41. https://pubmed.ncbi.nlm.nih.gov/33983151/.

  69. Food and Drug Administration Amendments Act (FDAAA) of 2007 [Internet]. Office of the Commissioner; [cited 2018 Aug 21]. https://www.fda.gov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/foodanddrugadministrationamendmentsactof2007/default.htm.

  70. Prospero-International prospective register of systematic reviews [Internet]. [cited 2018 Aug 20]. https://www.crd.york.ac.uk/prospero/.

  71. Krleža-Jeric K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Rev Panam Salud Publica [Internet]. 2011 Jul [cited 2016 Jun 15];30(1):87–96. http://www.ncbi.nlm.nih.gov/pubmed/22159656.

  72. Australia Clinical Trials Toolkit | Australian Clinical Trials [Internet]. [cited 2018 Aug 21]. https://www.australianclinicaltrials.gov.au/clinical-trials-toolkit#overlay-context=home.

  73. Pienaar E. Cochrane SA webinar: clinical trial registration and the Pan African Clinical Trials Registry—YouTube [Internet]. 2018 [cited 2022 May 7]. https://www.youtube.com/watch?v=BIMHoXXqyTA.

  74. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans [Internet]. TCPS 2. 2014. www.nserc-crsng.gc.ca.

  75. Australia New Zealand Clinical Trials Registry. Data item definition/explanation [Internet]. [cited 2018 Aug 13]. http://www.anzctr.org.au/docs/ANZCTRDatafieldexplanationV5.pdf.

  76. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med [Internet]. 2005;353(26):2779–87. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568386/.

  77. Askie LM, Hunter KE, Berber S, Langford A, Tan-Koay AG, Vu T, Sausa R, Seidler AL, Ko H SRJ. The Clinical Trials Landscape in Australia 2006–2015 [Internet]. Sydney: Australian New Zealand Clinical Trials Registry; 2017 [cited 2018 Aug 18]. 83 p. http://www.anzctr.org.au/docs/ClinicalTrialsInAustralia2006-2015.pdf#page=1&zoom=auto,557,766.

  78. Zarin DA, Califf RM. Trial reporting and the clinical trials enterprise. JAMA Intern Med [Internet]. 2021 [cited 2022 Mar 14];181(8):1131–2. https://pubmed.ncbi.nlm.nih.gov/34028521/.

  79. Speich B, Gloy VL, Klatte K, Gryaznov D, Taji Heravi A, Ghosh N, et al. Reliability of trial information across registries for trials with multiple registrations: a systematic review + supplemental content. JAMA Network Open [Internet]. 2021 [cited 2022 Jan 29];4(11):2128898. https://jamanetwork.com/.

  80. DeVito NJ, Goldacre B. Trends and variation in data quality and availability on the European Union Clinical Trials register: a cross-sectional study. Clin Trials [Internet]. 2022 [cited 2022 Mar 19]. https://pubmed.ncbi.nlm.nih.gov/35144496/.

  81. Paludan-Müller AS, Maclean-Nyegaard IR, Munkholm K. Substantial delays in clinical data published by the European Medicines Agency—a cross sectional study. J Clin Epidemiol [Internet]. 2022;146:68–76. https://doi.org/10.1016/j.jclinepi.2022.02.004.

  82. Ghersi D, Clarke M, Berlin J, Gülmezoglu AM, Kush R, Lumbiganon P, et al. Reporting the findings of clinical trials: a discussion paper. Bull World Health Organ [Internet]. 2008;86(6). http://www.icmje.

  83. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database—update and key issues. N Engl J Med [Internet]. 2011;364(9):852–860. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066456/.

  84. Speich B, Gryaznov D, Busse JW, Gloy VL, Lohner S, Klatte K, et al. Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis. Kesselheim AS, editor. PLoS Med [Internet]. 2022 [cited 2022 May 20];19(4):e1003980. https://dx.plos.org/10.1371/journal.pmed.1003980.

  85. Riedel N, Wieschowski S, Bruckner T, Holst MR, Kahrass H, Nury E, et al. Results dissemination from completed clinical trials conducted at German university medical centers remained delayed and incomplete. The 2014–2017 cohort. J Clin Epidemiol [Internet]. 2022 [cited 2022 May 5];144:1–7. https://pubmed.ncbi.nlm.nih.gov/34906673/.

  86. Moorthy VS, Karam G, Vannice KS, Kieny MP. Rationale for WHO’s new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med. 2015;12(4):e1001819.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Krleza-Jeric K. International dialogue on the public reporting of clinical trial outcome and results—PROCTOR meeting. Croat Med J. 2008;49:267–8.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Krleža-Jerić K, Gabelica M, Banzi R, Krnić-Martinić M, Pulido B, Mahmić-Kaknjo M, et al. IMPACT Observatory: tracking the evolution of clinical trial data sharing and research integrity. Biochem Med (Zagreb) [Internet]. 2016 [cited 2022 Apr 3];26(3):308–17. https://pubmed.ncbi.nlm.nih.gov/27812300/.

  89. Mahmić-Kaknjo M, Šimić J, Krleža-Jerić K. Setting the IMPACT (Improve access to clinical trial data) observatory baseline. Biochem Med [Internet]. 2018 [cited 2022 Jun 4];28(1):010201. https://www.biochemia-medica.com/en/journal/28/10.11613/BM.2018.010201.

  90. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet [Internet]. 2014 [cited 2016 Jul 14];383(9913):257–66. http://www.ncbi.nlm.nih.gov/pubmed/24411650.

  91. Ohmann C, Banzi R, Canham S, Battaglia S, Matei M, Ariyo C, et al. Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open [Internet]. 2017;7(12):e018647. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736032/.

  92. World Health Organization. WHO statement on public disclosure of clinical trial results [Internet]. 2015 [cited 2016 Jul 11]. http://www.who.int/ictrp/results/reporting/en/.

  93. Woodcock J. FDA Takes action for failure to submit required clinical trial results information to ClinicalTrials.gov | FDA [Internet]. 2021 [cited 2022 Mar 30]. https://www.fda.gov/news-events/press-announcements/fda-takes-action-failure-submit-required-clinical-trial-results-information-clinicaltrialsgov.

  94. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use [Internet]. 2019 [cited 2022 May 12]. https://www.ema.europa.eu/en/documents/other/european-medicines-agency-policy-publication-clinical-data-medicinal-products-human-use_en.pdf.

  95. DeVito NJ, Goldacre B. New EU trial reporting regulations must be enforced. BMJ. 2022;376:o410.

    Article  PubMed  Google Scholar 

  96. Strzebonska K, Wasylewski MT, Zaborowska L, Riedel N, Wieschowski S, Strech D, et al. Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis. BMJ Open. 2020;10:34666.

    Article  Google Scholar 

  97. Mayo-Wilson E, Heyward J, Keyes A, Reynolds J, White S, Atri N, et al. Clinical trial registration and reporting: a survey of academic organizations in the United States. BMC Med. 2018;16(1):60.

    Article  PubMed  PubMed Central  Google Scholar 

  98. European Medicine Agency. Clinical Trials Information System | European Medicines Agency [Internet]. 2022 [cited 2022 May 4]. https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/clinical-trials-information-system.

  99. EU Trials Tracker—Who’s not sharing clinical trial results? [Internet]. [cited 2022 Mar 30]. https://eu.trialstracker.net/.

  100. Dal-Ré R, Goldacre B, Mahillo-Fernández I, DeVito NJ. European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry. J Clin Epidemiol. 2022;(142):161–70.

    Google Scholar 

  101. Gao L, Guo R, Han Z, Liu J, Chen X. Clinical trial reporting. Lancet [Internet]. 2020 [cited 2022 May 7];396(10261):1488–9. http://www.thelancet.com/article/S0140673620322650/fulltext.

  102. Chan AW, Hróbjartsson A. Promoting public access to clinical trial protocols: challenges and recommendations. Trials [Internet]. 2018. https://doi.org/10.1186/s13063-018-2510-1.

  103. Bian ZX, Wu TX. Legislation for trial registration and data transparency. Trials [Internet]. 2010;11(1):64. https://doi.org/10.1186/1745-6215-11-64.

  104. Collins F. Has the revolution arrived? Nature [Internet]. 2010;464(7289):674–5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101928/.

  105. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature [Internet]. 2003;422:835. https://doi.org/10.1038/nature01626

  106. Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors. Ethiop J Health Sci. 2017;27(4):315–8.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials [Internet]. 2011;12:249. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264537/.

  108. Rockhold F, Bromley C, Wagner EK, Buyse M. Open science: the open clinical trials data journey. Clin Trials [Internet]. 2019 [cited 2022 Mar 19];16(5):539–46. https://journals.sagepub.com/doi/10.1177/1740774519865512.

  109. Rockhold F, Nisen P, Freeman A. Data sharing at a crossroads. NEJM. 2016;375:1115–7.

    Article  PubMed  Google Scholar 

  110. Re3Data; Registry of Research Data Repositories [Internet]. [cited 2018 Aug 11]. www.Re3data.org.

  111. Edinburgh DataShare [Internet]. [cited 2018 Aug 18]. https://datashare.is.ed.ac.uk/.

  112. DRUM. Data Repository for U of M (DRUM) [Internet]. [cited 2022 Jun 12]. https://conservancy.umn.edu/drum.

  113. Krleza-Jeric K, Hrynaszkiewicz I. Environmental scan of repositories of clinical research data: how far have we got with public disclosure of trial data? [Internet]. figshare; 2018. https://figshare.com/articles/Environmental_Scan_of_Repositories_of_Clinical_Research_Data_How_Far_Have_We_Got_With_Public_Disclosure_of_Trial_Data_/5755386.

  114. Gabelica M, Martinic MK, Luksic D, Krleza-Jeric K. Clinical trial transparency and data repositories; an environmental scan of the IMPACT (Improving access to clinical trial data) Observatory [Internet]. figshare; 2018. https://figshare.com/articles/Clinical_trial_transparency_and_data_repositories_an_environmental_scan_of_the_IMPACT_Improving_Access_to_Clinical_Trial_Data_Observatory/7390559.

  115. Krleža-Jerić K, Gabelica M, Banzi R, Martinić MK, Pulido B, Mahmić-Kaknjo M, et al. IMPACT observatory: tracking the evolution of clinical trial data sharing and research integrity. Biochem Med (Zagreb) [Internet]. 2016;26(3):308–17. http://www.ncbi.nlm.nih.gov/pubmed/27812300%0A, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5082220.

  116. NIH. NIH Office of Data Science Strategy Announces New Initiative to Improve Access to NIH-funded Data | Data Science at NIH [Internet]. 2022 [cited 2022 May 28]. https://datascience.nih.gov/news/nih-office-of-data-science-strategy-announces-new-initiative-to-improve-data-access.

  117. The Dataverse Project [Internet]. [cited 2018 Aug 18]. https://dataverse.org/.

  118. Harvard Dataverse [Internet]. [cited 2018 Aug 19]. https://dataverse.harvard.edu/.

  119. Research Data Alliance RDA [Internet]. [cited 2018 Aug 16]. https://www.rd-alliance.org/about-rda/who-rda.html.

  120. CoreTrustSeal [Internet]. [cited 2018 Jun 27]. https://www.coretrustseal.org/about/.

  121. Pampel H, Vierkant P, Scholze F, Bertelmann R, Kindling M, Klump J, et al. Making research data repositories visible: the re3data.org registry. PLoS One. 2013;8(11):e78080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Persistent Identifier [Internet]. [cited 2018 Aug 18]. https://en.wikipedia.org/wiki/Persistent_identifier.

  123. DataCite [Internet]. [cited 2018 Aug 11]. https://www.datacite.org/index.html.

  124. Scaiano M, Middleton G, Arbuckle L, Kolhatkar V, Peyton L, Dowling M, et al. A unified framework for evaluating the risk of re-identification of text de-identification tools. J Biomed Inform [Internet]. 2016 [cited 2022 May 10];63:174–83. https://doi.org/10.1016/j.jbi.2016.07.015.

  125. Willenborg L, de Waal T. Elements of statistical disclosure control. New York: Springer New York; 2001. (Lecture Notes in Statistics; vol. 155).

    Google Scholar 

  126. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use: policy 0070 [Internet]. 2014 [cited 2022 May 10]. www.ema.europa.eu/contact.

  127. Health Canada. Guidance document on public release of clinical information: profile page—Canada.ca [Internet]. 2019 [cited 2022 May 10]. https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/profile-public-release-clinical-information-guidance.html.

  128. El Emam K, Lucy Mosquera RH. Practical synthetic data generation balancing privacy and the broad availability of data. Sebastopol: O’Reilly Media, 2020 [Internet]. 2020 [cited 2022 May 10];166. https://www.oreilly.com/library/view/practical-synthetic-data/9781492072737/.

  129. El Emam K, Jonker E, Arbuckle L, Malin B. A systematic review of re-identification attacks on health data. PLoS One [Internet]. 2011. www.plosone.org.

  130. MDR. ECRIN-MDR Wiki [Internet]. 2020 [cited 2022 Jun 14]. http://ecrin-mdr.online/index.php/Project_Overview.

Download references

Acknowledgments

The authors would like to thank Nevena Jeric, Apropo Media for graphic design.

Disclaimer

The views expressed here are the authors’ and do not represent the views of any organization.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Krleža-Jerić, K., Mahmić-Kaknjo, M., El Emam, K. (2023). Clinical Trial Registries, Results Databases, and Research Data Repositories. In: Richesson, R.L., Andrews, J.E., Fultz Hollis, K. (eds) Clinical Research Informatics. Health Informatics. Springer, Cham. https://doi.org/10.1007/978-3-031-27173-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-27173-1_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-27172-4

  • Online ISBN: 978-3-031-27173-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics